CIK 0000096943
- Large accelerated filer
TELEFLEX INC
Sign in to watch- Ticker
- TFX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 231147939
- Phone
- +1 610-225-6800
- Business address
- 550 E SWEDESFORD RD, SUITE 400, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-11 | Kelly Liam Chairman, President & CEO | Shares withheld for taxes | −3,622 | $259.48 | $940K | 18,228.29 |
| 2023-01-11 | Kelly Liam Chairman, President & CEO | Exercise or conversion | +3,579 | $82.26 | $294K | 21,807.29 |
| 2023-01-11 | Kelly Liam Chairman, President & CEO | Shares withheld for taxes | −2,173 | $259.48 | $564K | 19,634.29 |
| 2023-01-11 | Kelly Liam Chairman, President & CEO | Exercise or conversion · Stock Option / (Right to Buy) | +3,579 | 0 | ||
| 2023-01-11 | Kelly Liam Chairman, President & CEO | Exercise or conversion · Stock Option / (Right to Buy) | +6,040 | 0 | ||
| 2022-12-30 | Kelly Liam Chairman, President & CEO | Exercise or conversion | +16,343 | $78.62 | $1.3M | 32,153.29 |
| 2022-12-30 | Kelly Liam Chairman, President & CEO | Sale | −16,340 | $250.03 | $4.1M | 15,813.29 |
| 2022-12-30 | Kelly Liam Chairman, President & CEO | Sale | −3 | $251.00 | $753 | 15,810.29 |
| 2022-12-30 | Kelly Liam Chairman, President & CEO | Exercise or conversion · Stock Option / (Right to Buy) | −16,343 | 6,040 | ||
| 2022-06-07 | RANDLE STUART A Director | Exercise or conversion | +3,014 | $78.50 | $237K | 7,334 |
| 2022-06-07 | RANDLE STUART A Director | Sale | −3,014 | $283.31 | $854K | 4,320 |
| 2022-06-07 | RANDLE STUART A Director | Exercise or conversion · Stock Option / (Right to Buy) | −3,014 | 0 | ||
| 2022-05-03 | Patil Neena M Director | Grant or award | +399 | 399 | ||
| 2022-05-03 | Patil Neena M Director | Grant or award · Stock Option / (Right to Buy) | +1,937 | 1,937 | ||
| 2022-05-03 | RANDLE STUART A Director | Grant or award | +399 | 4,320 | ||
| 2022-05-03 | RANDLE STUART A Director | Grant or award · Stock Option / (Right to Buy) | +969 | 969 | ||
| 2022-05-03 | HEINMILLER JOHN C Director | Grant or award | +399 | 1,949 | ||
| 2022-05-03 | HEINMILLER JOHN C Director | Grant or award · Stock Option / (Right to Buy) | +969 | 969 | ||
| 2022-05-03 | Klasko Stephen K. M.D. Director | Grant or award | +399 | 1,827.54 | ||
| 2022-05-03 | Klasko Stephen K. M.D. Director | Grant or award · Stock Option / (Right to Buy) | +969 | 969 |
Page 14 of 24 · 477 trades